PAI-1 is involved in delayed bone repair induced by glucocorticoids in mice

Area of Science:

• Bone biology
• Endocrinology
• Cellular and molecular medicine

Background:

• Glucocorticoids (GCs) are known to induce osteoporosis and may impair bone repair.
• The precise mechanisms underlying GC-induced delayed bone healing remain incompletely understood.
• Plasminogen activator inhibitor-1 (PAI-1) is implicated in various biological processes, including tissue repair.

Purpose of the Study:

• To investigate the role of PAI-1 in glucocorticoid-induced delayed bone repair following femoral injury in mice.
• To elucidate the molecular mechanisms by which PAI-1 influences GC effects on bone healing.

Main Methods:

• Utilized female mice with PAI-1 deficiency and wild-type littermates subjected to femoral bone injury.
• Administered Dexamethasone (Dex), a synthetic GC, to assess its effects on bone repair and PAI-1 levels.
• Quantified PAI-1 mRNA and protein levels, Runx2 mRNA expression, and osteoblast apoptosis at the injury site.
• Evaluated adipogenic gene expression in response to Dex treatment.

Main Results:

• Dexamethasone increased plasma PAI-1 levels and PAI-1 mRNA in adipose and muscle tissues of wild-type mice.
• PAI-1 deficiency significantly ameliorated Dexamethasone-induced delayed bone repair.
• PAI-1 deficiency reversed Dexamethasone-induced suppression of Runx2 mRNA levels and osteoblast apoptosis.
• PAI-1 deficiency did not alter Dexamethasone-enhanced adipogenic gene expression at the injury site.

Conclusions:

• PAI-1 plays a significant role in mediating glucocorticoid-induced delayed bone repair in mice.
• PAI-1 may impact early osteoblast differentiation and apoptosis during the bone healing process.
• Targeting PAI-1 could be a potential therapeutic strategy to counteract GC-induced bone repair deficits.